How to buy CME Group (CME) stocks

CME Group is a financial data & stock exchanges business based in the US. CME Group shares (CME) are listed on the NASDAQ and all prices are listed in US Dollars.

Its last market close was $238.53 – an increase of 0.56% over the previous week. CME Group employs 3,565 staff and has a trailing 12-month revenue of around $6 billion.

Our top picks for where to buy CME Group stock

Buy CME Group stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

CME Group stock price (NASDAQ: CME)

Use our graph to track the performance of CME stocks over time.

CME Group stocks at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$238.53
52-week range	$188.79 - $247.82
50-day moving average more info button	$229.43
200-day moving average more info button	$213.73
Wall St. target price	$239.81
PE ratio more info button	24.9295
Dividend yield more info button	$4.55 (4.39%)
Earnings per share (TTM) more info button	$9.51

Is it a good time to buy CME Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

CME Group price performance over time

Historical closes compared with the close of $236.82 from 2024-12-19

1 week (2024-12-13)	-0.16%
1 month (2024-11-21)	4.53%
3 months (2024-09-20)	11.10%
6 months (2024-06-21)	21.77%

1 year (2023-12-21)	10.78%
2 years (2022-12-21)	50.61%
3 years (2021-12-21)	19.67%
5 years (2019-12-20)	41.49%

Is CME Group stock undervalued or overvalued?

Valuing CME Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CME Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

CME Group's P/E ratio

CME Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, CME Group shares trade at around 25x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stock or simply that they're under-valued.

CME Group's PEG ratio

CME Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 8.1962. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CME Group's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

CME Group's EBITDA

CME Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.2 billion.

The EBITDA is a measure of a CME Group's overall financial performance and is widely used to measure a its profitability.

CME Group financials

Revenue TTM	$6 billion
Operating margin TTM	64.75%
Gross profit TTM	$5 billion
Return on assets TTM	1.84%
Return on equity TTM	12.3%
Profit margin	57.43%
Book value	$78.47
Market Capitalization more info button	$85.4 billion

TTM: trailing 12 months

CME Group stock dividends

Dividend payout ratio: 91.49% of net profits

Recently CME Group has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CME Group shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In CME Group's case, that would currently equate to about $4.55 per share.

CME Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

CME Group's most recent dividend payout was on 15 January 2025. The latest dividend was paid out to all shareholders who bought their stocks by 26 December 2024 (the "ex-dividend date").

Have CME Group's stocks ever split?

CME Group's stocks were split on a 5:1 basis on 22 July 2012 . So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your CME Group stocks – just the quantity. However, indirectly, the new 80% lower stock price could have impacted the market appetite for CME Group stocks, which in turn could have impacted CME Group's stock price.

CME Group stock price volatility

Over the last 12 months, CME Group's stocks have ranged in value from as little as $188.7941 up to $247.8237. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while CME Group's is 0.559. This would suggest that CME Group's stocks are less volatile than average (for this exchange).

CME Group overview

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of CME Group is owned by insiders or institutions?
Currently 0.451% of CME Group stocks are held by insiders and 89.56% by institutions. How many people work for CME Group?
Latest data suggests 3,565 work at CME Group. When does the fiscal year end for CME Group?
CME Group's fiscal year ends in December. Where is CME Group based?
CME Group's address is: 20 South Wacker Drive, Chicago, IL, United States, 60606 What is CME Group's ISIN number?
CME Group's international securities identification number is: US12572Q1058 What is CME Group's CUSIP number?
CME Group's Committee on Uniform Securities Identification Procedures number is: 167760107

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.